asiatic acid has been researched along with isoniazid in 1 studies
| Studies (asiatic acid) | Trials (asiatic acid) | Recent Studies (post-2010) (asiatic acid) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 289 | 3 | 232 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | asiatic acid (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Huang, Y; Long, Y; Qiu, Y; Shi, Y; Su, H; Wei, J; Wei, Y; Zhu, W | 1 |
1 other study(ies) available for asiatic acid and isoniazid
| Article | Year |
|---|---|
Asiatic acid ameliorates rifampicin- and isoniazid-induced liver injury in vivo by regulating sphingolipid metabolism and mitogen-activated protein kinase signalling pathways.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Inflammation; Isoniazid; Liver; Mice; Mitogen-Activated Protein Kinases; Rifampin | 2023 |